These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7863934)
21. MR of corticotropin-secreting pituitary microadenomas. Colombo N; Loli P; Vignati F; Scialfa G AJNR Am J Neuroradiol; 1994 Sep; 15(8):1591-5. PubMed ID: 7985584 [TBL] [Abstract][Full Text] [Related]
22. Gadolinium-enhanced magnetization transfer contrast imaging of intracranial tumors. Kurki TJ; Niemi PT; Lundbom N J Magn Reson Imaging; 1992; 2(4):401-6. PubMed ID: 1633392 [TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T. Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376 [TBL] [Abstract][Full Text] [Related]
24. Dynamic contrast-enhanced MR imaging of the pituitary gland with fast spin-echo technique. Davis WL; Lee JN; King BD; Harnsberger HR J Magn Reson Imaging; 1994; 4(3):509-11. PubMed ID: 8061456 [TBL] [Abstract][Full Text] [Related]
25. Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas. Aronen HJ; Peltonen TK; Tanttu JI; Sipilä LM; Ruhala MT; Jääskeläinen J; Sepponen R Acad Radiol; 1996 Aug; 3 Suppl 2():S170-2. PubMed ID: 8796553 [No Abstract] [Full Text] [Related]
26. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns. Strouse PJ; Prince MR; Chenevert TL Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of intervertebral disks with gadolinium complexes: comparison of an ionic and a nonionic medium in an animal model. Ibrahim MA; Haughton VM; Hyde JS AJNR Am J Neuroradiol; 1994 Nov; 15(10):1907-10. PubMed ID: 7863940 [TBL] [Abstract][Full Text] [Related]
28. Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentetate dimeglumine and iron oxide particles. Reith W; Forsting M; Vogler H; Heiland S; Sartor K AJNR Am J Neuroradiol; 1995 Jan; 16(1):53-60. PubMed ID: 7900602 [TBL] [Abstract][Full Text] [Related]
29. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Yuh WT; Fisher DJ; Engelken JD; Greene GM; Sato Y; Ryals TJ; Crain MR; Ehrhardt JC Radiology; 1991 Aug; 180(2):485-91. PubMed ID: 2068317 [TBL] [Abstract][Full Text] [Related]
30. Ultra-low field MR imaging of hepatic hemangiomas (at 0.02 and 0.04 T). Ekelund L; Björnebrink J; Athlin L Eur J Radiol; 1992; 14(1):41-5. PubMed ID: 1563403 [TBL] [Abstract][Full Text] [Related]
31. Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer. Finelli DA; Hurst GC; Gullapali RP; Bellon EM Radiology; 1994 Feb; 190(2):553-9. PubMed ID: 8284415 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T. Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196 [TBL] [Abstract][Full Text] [Related]
33. A comparative study on contrast enhancement between 0.5- and 2.0-Tesla field strength in rabbit VX2 carcinomas. Ra DG; Chang KH; Han MH; Lee HJ; Yeon KM Invest Radiol; 1995 May; 30(5):291-5. PubMed ID: 7558733 [TBL] [Abstract][Full Text] [Related]
34. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging. Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127 [TBL] [Abstract][Full Text] [Related]
35. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas. Nakamura T; Schörner W; Bittner RC; Felix R Neuroradiology; 1988; 30(6):481-6. PubMed ID: 3226534 [TBL] [Abstract][Full Text] [Related]
36. Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength. Haustein J; Laniado M; Niendorf HP; Hilbertz T; Planitzer J; Schörner W; Louton T AJNR Am J Neuroradiol; 1992; 13(4):1199-206. PubMed ID: 1636537 [TBL] [Abstract][Full Text] [Related]